Skip to main content

Advertisement

Log in

In-Silico Design of a Multi‑epitope Construct Against Influenza A Based on Nucleoprotein Gene

  • Published:
International Journal of Peptide Research and Therapeutics Aims and scope Submit manuscript

Abstract

Influenza A virus infections are one of the most important factors that are still considered as global health concerns. The best and most effective defense against these infections is vaccination. Due to the limitations of current vaccines, vaccine design based on bioinformatics methods is receiving a lot of attention. Hence, in the present study, using a novel immunoinformatics methodology, we have intentioned an Influenza multi-epitope vaccine based on the greatly conserved and antigenic epitopes of Influenza virus nucleoprotein. The nucleoprotein (NP) of Influenza A virus displays an essential character in the vital functions of the virus so it can be used as a goal protein for vaccine design. The purpose of this vaccine is to induce humoral and cellular immune responses through epitopes in the np protein against influenza A viruses. Nucleoprotein sequences were analyzed by in-silico tools to predict and identify the most immunogenic B and T cell epitopes. The multi-epitope vaccine was designed using specific and proper linkers. We also explored the physicochemical properties of the planned construct to approve its thermodynamic stability, hydrophilicity, PI, antigenicity, and allergenicity. In addition, the modeled and optimized tertiary structure was predicted to be usable for further procedure. The molecular docking of the TLR3/4 and designed vaccine illustrates engaged binding. Taken together, these outcomes propose that the structure of our multi-epitope vaccine may offer strong immunizations beside dissimilar strains of influenza virus subtypes, thus evading the requirement for yearly vaccine re-formulation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12

Similar content being viewed by others

References

  • Ahmad S, Shahid F, Tahir ul Qamar M, Rehman H, Abbasi SW, Sajjad W, Ismail S, Alrumaihi F, Allemailem KS, Almatroudi A (2021) Immuno-informatics analysis of PAKISTAN-based HCV subtype-3a for chimeric polypeptide vaccine design. Vaccines 9(3):293

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Al Hassan YT, Fabella EL, Estrella ED, Al Ramadan HA, Al Rajeh AM, Al Saleh FH (2021) Association of vaccine awareness and confidence on the influenza vaccination status of Al Ahsa, Saudi Arabia residents. Hum Vacc Immunother 17(7):2190–2196

    Article  CAS  Google Scholar 

  • Alam A, Ali S, Ahamad S, Malik MZ, Ishrat R (2016) From ZikV genome to vaccine: in silico approach for the epitope-based peptide vaccine against Zika virus envelope glycoprotein. Immunology 149(4):386–399

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bahrami AA, Bandehpour M, Khalesi B, Kazemi B (2020) Computational design and analysis of a poly-epitope fusion protein: a new vaccine candidate for Hepatitis and Poliovirus. Int J Pept Res Ther 26(1):389–403

    Article  CAS  Google Scholar 

  • Bassani-Sternberg M, Gfeller D (2016) Unsupervised HLA peptidome deconvolution improves ligand prediction accuracy and predicts cooperative effects in peptide–HLA interactions. J Immunol 197(6):2492–2499

    Article  CAS  PubMed  Google Scholar 

  • Behbahani M, Moradi M, Mohabatkar H (2021) In silico design of a multi-epitope peptide construct as a potential vaccine candidate for Influenza A based on neuraminidase protein. In Silico Pharmacol 9(1):1–13

    Article  Google Scholar 

  • Bhatnager R, Bhasin M, Arora J, Dang AS (2021) Epitope based peptide vaccine against SARS-COV2: an immune-informatics approach. J Biomol Struct Dyn 39(15):5690–5705

    Article  CAS  PubMed  Google Scholar 

  • Bibi S, Ullah I, Zhu B, Adnan M, Liaqat R, Kong W-B, Niu S (2021) In silico analysis of epitope-based vaccine candidate against tuberculosis using reverse vaccinology. Sci Rep 11(1):1–16

    Article  CAS  Google Scholar 

  • Biswas A, Chakrabarti AK, Dutta S (2020) Current challenges: from the path of “original antigenic sin” towards the development of universal flu vaccines: flu vaccine efficacy encounters significant hurdles from pre-existing immunity of the host suggesting assessment of host immunity before vaccination. Int Rev Immunol 39(1):21–36

    Article  CAS  PubMed  Google Scholar 

  • Chang D, Zaia J (2019) Why glycosylation matters in building a better flu vaccine. Mol Cell Proteomics 18(12):2348–2358

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chauhan G, Madou MJ, Kalra S, Chopra V, Ghosh D, Martinez-Chapa SO (2020) Nanotechnology for COVID-19: therapeutics and vaccine research. ACS Nano 14(7):7760–7782

    Article  CAS  PubMed  Google Scholar 

  • Choudhary MI, Shaikh M, tul-Wahab A, ur-Rahman A (2020) In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation. PLoS ONE 15(7):e0235030

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Clark DR, McKew BA, Binley A, Heppell CM, Whitby C, Trimmer M (2022) Hydrological properties predict the composition of microbial communities cycling methane and nitrogen in rivers. ISME Communications 2(1):1–9

    Article  Google Scholar 

  • Cohen IR, Efroni S (2019) The immune system computes the state of the body: crowd wisdom, machine learning, and immune cell reference repertoires help manage inflammation. Front Immunol 10:10

    Article  PubMed  PubMed Central  Google Scholar 

  • Dewi IP (2017) B-cell epitope prediction of Mycobacterium tuberculosis Ag85A antigen. UNEJ e-Proceeding, pp 108–111

  • Dhanda SK, Mahajan S, Paul S, Yan Z, Kim H, Jespersen MC, Jurtz V, Andreatta M, Greenbaum JA, Marcatili P (2019) IEDB-AR: immune epitope database—analysis resource in 2019. Nucleic Acids Res 47(W1):W502–W506

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ebrahim-Saraie HS, Dehghani B, Mojtahedi A, Shenagari M, Hasannejad-Bibalan M (2021) Functional and structural characterization of SARS-cov-2 spike protein: an in silico study. Ethiopian J Health Sci 31(2)

  • Eisfeld AJ, Neumann G, Kawaoka Y (2015) At the centre: influenza A virus ribonucleoproteins. Nat Rev Microbiol 13(1):28–41

    Article  CAS  PubMed  Google Scholar 

  • Englmeier L (2020) A theory on SARS-CoV-2 susceptibility: low sensitivity of tlr7-signalling as a mechanistic explanation for the increased risk of obese and elderly COVID-19 patients."

  • Fotouhi F, Shaffifar M, Farahmand B, Shirian S, Saeidi M, Tabarraei A, Gorji A, Ghaemi A (2017) Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus. Adv Virol 162(5):1251–1260

    CAS  Google Scholar 

  • Foy BH, Wahl B, Mehta K, Shet A, Menon GI, Britto C (2021) Comparing COVID-19 vaccine allocation strategies in India: a mathematical modelling study. Int J Infect Dis 103:431–438

    Article  CAS  PubMed  Google Scholar 

  • Girija AS, Shoba G, Priyadharsini JV (2021) Accessing the T-Cell and B-Cell immuno-dominant peptides from A. baumannii biofilm associated protein (bap) as vaccine candidates: a computational approach. Int J Pept Res Ther 27(1):37–45

    Article  CAS  Google Scholar 

  • Goldberg SB, Tucker RP, Greene PA, Davidson RJ, Wampold BE, Kearney DJ, Simpson TL (2018) Mindfulness-based interventions for psychiatric disorders: a systematic review and meta-analysis. Clin Psychol Rev 59:52–60

    Article  PubMed  Google Scholar 

  • Han VX, Jones HF, Patel S, Mohammad SS, Hofer MJ, Alshammery S, Maple-Brown E, Gold W, Brilot F, Dale RC (2022) Emerging evidence of Toll-like receptors as a putative pathway linking maternal inflammation and neurodevelopmental disorders in human offspring: a systematic review. Brain Behav Immun 99:91–105

    Article  CAS  PubMed  Google Scholar 

  • Hu Z, van der Ploeg K, Chakraborty S, Arunachalam P, Mori DM, Jacobson KB, Bonilla H, Parsonnet J, Andrews J, Hedlin H (2021) Early immune responses have long-term associations with clinical, virologic, and immunologic outcomes in patients with COVID-19. medRxiv

  • Iwasaki A, Pillai PS (2014) Innate immunity to influenza virus infection. Nat Rev Immunol 14(5):315–328

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jabalia N, Kumar A, Kumar V, Rani R (2021). In silico approach in drug design and drug discovery: an update. In: Innovations and implementations of computer aided drug discovery strategies in rational drug design. Springer, pp 245–271

  • Joshi A, Joshi BC, Mannan MA-U, Kaushik V (2020) Epitope based vaccine prediction for SARS-COV-2 by deploying immuno-informatics approach. Inform Med Unlocked 19:100338

    Article  PubMed  PubMed Central  Google Scholar 

  • Kumar TA (2013) CFSSP: Chou and Fasman secondary structure prediction server. Wide Spectrum 1(9):15–19

    Google Scholar 

  • Kumar AU, Kadiresen K, Gan WC, Ling APK (2021) Current updates and research on plant-based vaccines for coronavirus disease 2019. Clin Exp Vacc Res 10(1):13

    Article  CAS  Google Scholar 

  • Kumar A, Sharma P, Arun A, Meena LS (2022) Development of peptide vaccine candidate using highly antigenic PE-PGRS family proteins to stimulate the host immune response against Mycobacterium tuberculosis H37Rv: an immuno-informatics approach. J Biomol Struct Dyn 4:1–23

    Google Scholar 

  • Laskowski RA, Jabłońska J, Pravda L, Vařeková RS, Thornton JM (2018) PDBsum: structural summaries of PDB entries. Protein Sci 27(1):129–134

    Article  CAS  PubMed  Google Scholar 

  • Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, Pan P, Wang W, Hu D, Liu X (2020a) Coronavirus infections and immune responses. J Med Virol 92(4):424–432

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Li Q-Y, Xu M-M, Dong H, Zhao J-H, Xing J-H, Wang G, Yao J-Y, Huang H-B, Shi C-W, Jiang Y-L (2020b) Lactobacillus plantarum surface-displayed influenza antigens (NP-M2) with FliC flagellin stimulate generally protective immune responses against H9N2 influenza subtypes in chickens. Vet Microbiol 249:108834

    Article  CAS  PubMed  Google Scholar 

  • Liu C-Y, Yang Y, Zhang X-M, Xu X, Dou Q-L, Zhang W-W, Cheng AS (2020) The prevalence and influencing factors in anxiety in medical workers fighting COVID-19 in China: a cross-sectional survey. Epidemiol Infect. https://doi.org/10.1017/S0950268820001107

    Article  PubMed  PubMed Central  Google Scholar 

  • Mahant S, Sahajpal NS, Nanda S (2021) Insights into the mechanism of Cymbopogan martinii essential oil in topical therapy of acne vulgaris. Fut Microbiol 16(15):1181–1193

    Article  CAS  Google Scholar 

  • Maleki A, Russo G, Parasiliti Palumbo GA, Pappalardo F (2021) In silico design of recombinant multi-epitope vaccine against influenza A virus. BMC Bioinform 22(14):1–19

    Google Scholar 

  • Massari S, Desantis J, Nizi MG, Cecchetti V, Tabarrini O (2020) Inhibition of influenza virus polymerase by interfering with its protein–protein interactions. ACS Infect Dis 7(6):1332–1350

  • Patel MC, Shirey KA, Pletneva LM, Boukhvalova MS, Garzino-Demo A, Vogel SN, Blanco JC (2014) Novel drugs targeting Toll-like receptors for antiviral therapy. Futur Virol 9(9):811–829

    Article  CAS  Google Scholar 

  • Paul D, Sharif IH, Sayem A, Ahmed H, Saleh A, Mahmud S (2021). In silico prediction of a highly immunogenic and conserved epitope against Zika Virus. Inform Med Unlocked 100613

  • Plociennikowska A, Frankish J, Moraes T, Del Prete D, Kahnt F, Acuna C, Slezak M, Binder M, Bartenschlager R (2021) TLR3 activation by Zika virus stimulates inflammatory cytokine production which dampens the antiviral response induced by RIG-I-like receptors. J Virol 95(10):e01050-e11020

    Article  CAS  PubMed Central  Google Scholar 

  • Prajapat R, Marwal A, Gaur R (2014) Recognition of errors in the refinement and validation of three-dimensional structures of AC1 proteins of begomovirus strains by using ProSA-Web. J Virus 2014:1–6

    Article  Google Scholar 

  • Qamar MTU, Saba Ismail SA, Mirza MU, Abbasi SW, Ashfaq UA, Chen L-L (2021) Development of a novel multi-epitope vaccine against crimean-congo hemorrhagic fever virus: an integrated reverse vaccinology, vaccine informatics and biophysics approach. Front Immunol. https://doi.org/10.3389/fimmu.2021.669812

    Article  Google Scholar 

  • Rostaminia S, Aghaei SS, Farahmand B, Nazari R, Ghaemi A (2021) Computational design and analysis of a multi-epitope against influenza A virus. Int J Pept Res Therap 27:2625–2638

    Article  CAS  Google Scholar 

  • Sabbaghi A, Zargar M, Zolfaghari MR, Motamedi-Sedeh F, Ghaemi A (2021) Protective cellular and mucosal immune responses following nasal administration of a whole gamma-irradiated influenza A (subtype H1N1) vaccine adjuvanted with interleukin-28B in a mouse model. Adv Virol 166(2):545–557

    CAS  Google Scholar 

  • Samad A, Ahammad F, Nain Z, Alam R, Imon RR, Hasan M, Rahman MS (2020) Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach. J Biomol Struct Dyn. https://doi.org/10.1080/07391102.2020.1792347

    Article  PubMed  PubMed Central  Google Scholar 

  • Samad A, Ahammad F, Nain Z, Alam R, Imon RR, Hasan M, Rahman MS (2022) Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach. J Biomol Struct Dyn 40(1):14–30

    Article  CAS  PubMed  Google Scholar 

  • Schlessinger A, Yachdav G, Rost B (2006) PROFbval: predict flexible and rigid residues in proteins. Bioinformatics 22(7):891–893

    Article  CAS  PubMed  Google Scholar 

  • Selvaraj P, Lien CZ, Liu S, Stauft CB, Nunez IA, Hernandez M, Nimako E, Ortega MA, Starost MF, Dennis JU (2021) SARS-CoV-2 infection induces protective immunity and limits transmission in Syrian hamsters. Life Sci Allianc 4(4):e202000886

    Article  CAS  Google Scholar 

  • Shafiuddin M, Boon AC (2019) RNA Sequence features are at the core of influenza A virus genome packaging. J Mol Biol 431(21):4217–4228

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shahid F, Ashfaq UA, Javaid A, Khalid H (2020) Immunoinformatics guided rational design of a next generation multi epitope based peptide (MEBP) vaccine by exploring Zika virus proteome. Infect Genet Evol 80:104199

    Article  CAS  PubMed  Google Scholar 

  • Sharma S, Kumari V, Kumbhar BV, Mukherjee A, Pandey R, Kondabagil K (2021) Immunoinformatics approach for a novel multi-epitope subunit vaccine design against various subtypes of Influenza A virus. Immunobiology 226(2):152053

    Article  CAS  PubMed  Google Scholar 

  • Tsai SP, Howell DW, Huang Z, Hsiao HC, Lu Y, Matthews KS, Lou J, Bondos SE (2015) The effect of protein fusions on the production and mechanical properties of protein-based materials. Adv Funct Mater 25(9):1442–1450

    Article  CAS  Google Scholar 

  • Wang V, Xu N, Liu J-C, Tang G, Geng W-T (2021) VASPKIT: a user-friendly interface facilitating high-throughput computing and analysis using VASP code. Comput Phys Commun 267:108033

    Article  CAS  Google Scholar 

  • Weng G, Gao J, Wang Z, Wang E, Hu X, Yao X, Cao D, Hou T (2020) Comprehensive evaluation of fourteen docking programs on protein–peptide complexes. J Chem Theory Comput 16(6):3959–3969

    Article  CAS  PubMed  Google Scholar 

  • Wu J, Chen ZJ (2014) Innate immune sensing and signaling of cytosolic nucleic acids. Annu Rev Immunol 32:461–488

    Article  CAS  PubMed  Google Scholar 

  • Yan Y, Tao H, He J, Huang S-Y (2020) The HDOCK server for integrated protein–protein docking. Nat Protoc 15(5):1829–1852

    Article  CAS  PubMed  Google Scholar 

  • Yang F, Pang B, Lai KK, Cheung NN, Dai J, Zhang W, Zhang J, Chan K-H, Chen H, Sze K-H (2021) Discovery of a Novel specific inhibitor targeting influenza A Virus nucleoprotein with pleiotropic inhibitory effects on various steps of the viral life cycle. J Virol 95(9):e01432-e11420

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors would like to acknowledgement Pasteur institute of Iran for the financial support.

Funding

This work was supported by Pasteur Institute of Iran (Grant 1137).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Seyed Soheil Aghaei or Amir Ghaemi.

Ethics declarations

Conflict of interest

Authors declare there is no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rostaminia, S., Aghaei, S.S., Farahmand, B. et al. In-Silico Design of a Multi‑epitope Construct Against Influenza A Based on Nucleoprotein Gene. Int J Pept Res Ther 28, 117 (2022). https://doi.org/10.1007/s10989-022-10418-w

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10989-022-10418-w

Keywords

Navigation